Physician profile
Usman Siddiqui
NPI 1467623199
$1,233,914.24
in general payments reported to CMS, 2019-2025
51 companies · $253K in 2025
The $253K reported for 2025 was more than what 99% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $179K · 2020: $143K · 2021: $132K · 2022: $139K · 2023: $167K · 2024: $220K · 2025: $253K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $241K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $178K · Travel and Lodging: $172K · Food and Beverage: $33K · Honoraria: $16K · Entertainment: $26.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $240,820.77 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $178,176.50 |
| Travel and Lodging | $171,774.68 |
| Food and Beverage | $32,783.04 |
| Honoraria | $16,200.00 |
| Entertainment | $26.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $427,127.83 | 2019-2025 | Amplatzer Amulet, Tacticath Ablation Catheter, Sensor Enabled, Firmap |
| Medtronic, INC. | $316,207.89 | 2021-2025 | Affera Mapping System, Pulseselect, Micra |
| Acutus Medical, INC. | $133,658.77 | 2019-2023 | |
| Anumana, INC. | $54,000.00 | 2025 | Ecg-Ai Lef |
| Medtronic Vascular, INC. | $34,409.61 | 2019-2020 | |
| Medical Device Business Services, INC. | $34,023.37 | 2020-2025 | Carto 3 |
| Impulse Dynamics (USA) INC. | $33,498.24 | 2019-2025 | Optimizer, Optimizer |
| Avertix Medical, INC | $32,965.00 | 2023-2024 | |
| Biotronik INC. | $30,964.14 | 2019-2025 | Biomonitor, Acticor 7 Vr-T Dx, Solia |
| Boston Scientific Corporation | $26,252.98 | 2019-2025 | Watchman Access System, Farapulse, Cds - Mct/Cem Monitoring |
| Terumo Medical Corporation | $25,952.56 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $18,751.16 | 2019-2025 | Camzyos, Eliquis |
| Ge Healthcare | $14,168.00 | 2023-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $8,716.97 | 2019-2025 | Lifevest |
| Pulse Biosciences, INC. | $7,690.04 | 2024-2025 | Cellfx, Cellfx |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $7,461.92 | 2019-2024 | |
| Altathera Pharmaceuticals LLC | $6,765.33 | 2021-2023 | Sotalol Hydrochloride |
| Sanofi-Aventis U.S. LLC | $6,051.65 | 2019-2023 | |
| Siemens Medical Solutions USA, INC. | $5,930.05 | 2019-2025 | Acuson Sc2000 Diagnostic Ultrasound System, Acuson Origin Diagnostic Ultrasound System, Acuson S2000 Diagnostic Ultrasound System |
| Cardiva Medical, INC. | $2,351.47 | 2019-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Atricure, INC. | $1,815.99 | 2019-2023 | |
| Biosense Webster, INC. | $1,182.84 | 2019-2024 | Carto 3, Nuvision Ice Catheter |
| Vektor Medical INC. | $500.00 | 2024 | Vmap |
| Philips North America LLC | $466.83 | 2020-2023 | |
| Stereotaxis INC | $325.69 | 2019-2025 | Niobe, Genesis |
| Elutia, INC. | $306.90 | 2019-2022 | |
| Cardiofocus, INC. | $306.67 | 2019-2021 | |
| Cvrx, INC. | $284.92 | 2023-2025 | Barostim Neo System |
| Inari Medical, INC. | $194.85 | 2022 | |
| Janssen Pharmaceuticals, INC | $188.69 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals Lp | $161.03 | 2021-2024 | Farxiga |
| Merck Sharp & Dohme LLC | $150.78 | 2021-2024 | Verquvo |
| Haemonetics Corporation | $149.84 | 2021 | |
| Amgen INC. | $145.42 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $132.51 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $120.38 | 2022-2023 | Opsumit, Uptravi |
| Bard Peripheral Vascular, INC. | $106.09 | 2021 | |
| Cordis US Corp. | $81.76 | 2021-2024 | Mynx Control, Mynx Venous Vcd |
| Bardy Diagnostics, INC. | $52.00 | 2019-2021 | |
| Nuwellis, INC. | $47.63 | 2021 | |
| Edwards Lifesciences Corporation | $40.33 | 2020-2024 | |
| Esperion Therapeutics, INC. | $35.02 | 2022 | |
| Pfizer INC. | $34.82 | 2019-2023 | |
| Novo Nordisk INC | $30.93 | 2021-2022 | |
| Amarin Pharma, INC. | $20.48 | 2019 | |
| Acacia Pharma INC | $18.05 | 2022 | |
| Tactile Systems Technology INC | $15.90 | 2021 | |
| Daiichi Sankyo INC. | $13.88 | 2023 | Injectafer |
| Lexicon Pharmaceuticals, INC. | $12.72 | 2023 | Inpefa |
| Arbor Pharmaceuticals, INC. | $12.63 | 2021 | |
| Livanova USA, INC. | $11.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$925.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$48,173.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Usman Siddiqui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.